Mutations in BRCA2 increase susceptibility to breast, ovarian and prostate cancers. The product of human BRCA2, BRCA2 protein, has a key role in the repair of DNA double-strand breaks and interstrand cross-links by RAD51-mediated homologous recombination. Here, we present a biochemical and structural characterization of full-length (3,418 amino acid) BRCA2, alone and in complex with RAD51. We show that BRCA2 facilitates nucleation of RAD51 filaments at multiple sites on single-stranded DNA. Three-dimensional EM reconstructions revealed that BRCA2 exists as a dimer and that two oppositely oriented sets of RAD51 molecules bind the dimer. Single-stranded DNA binds along the long axis of BRCA2, such that only one set of RAD51 monomers can form a productive complex with DNA and establish filament formation. Our data define the molecular mechanism by which this tumor suppressor facilitates RAD51-mediated homologous-recombinational repair.
a r t i c l e s Many individuals carry genetic mutations that confer a predisposition to early-onset breast or ovarian cancers 1 . Of these familial cases, 30-50% are associated with mutations in the breast cancer susceptibility genes BRCA1 or BRCA2 (refs. 2,3). The cumulative incidence of breast cancer in germline BRCA2-mutant carriers approaches 80%, thus leading many women with familial history to make difficult choices relating to radical surgical approaches that can reduce the risk.
Each day, genomic DNA suffers tens of thousands of endogenous DNA-damage events due to the presence of metabolic byproducts, toxic chemicals and UV irradiation 4 . Unrepaired lesions caused by these agents are a contributing factor to genome instability and cancer development. One of the most serious forms of damage is the DNA double-strand break (DSB) because unrepaired or improperly repaired breaks can lead to mutation, chromosome translocation and deletion-all of which can contribute to cancer development-or to cell death 5 .
BRCA2 encodes BRCA2 protein (384 kDa), which is involved in the repair of DSBs by homologous recombination (HR) 6, 7 . A key step in HR is the recruitment of RAD51 recombinase to exposed singlestranded DNA (ssDNA) overhangs generated by the resection of DSB termini. RAD51 assembles on the ssDNA to form highly ordered helical nucleoprotein filaments that subsequently mediate the search for homologous sequences on the undamaged sister chromatid. The homology search is then followed by DNA strand exchange, which leads to the formation of recombination intermediates in which interacting DNAs become covalently linked.
Cells defective for BRCA2 are sensitive to DNA interstrand crosslinking agents and exhibit a decreased efficiency of DSB repair and an inability to promote the efficient restart of stalled replication forks [8] [9] [10] . They also fail to promote the nuclear relocalization of RAD51 after exogenous DNA damage 11, 12 . The inability to target RAD51 to sites of repair indicates that BRCA2 acts as a mediator for the formation of RAD51 filaments, a proposal supported by several other observations: (i) BRCA2 interacts with RAD51 through a cluster of eight conserved motifs, the BRC repeats, and an additional unrelated C-terminal RAD51-interaction domain [13] [14] [15] [16] [17] [18] ; (ii) mutations within the BRC repeats confer DNA-damage sensitivity 19 ; (iii) purified BRCA2 stimulates the formation of RAD51 nucleoprotein filaments in vitro [20] [21] [22] ; and (iv) overexpression of RAD51 suppresses the HR defects observed in BRCA2-depleted mouse cells 23 .
Beyond knowledge of the BRC repeats that interact with RAD51, knowledge relating to the functions of other regions of this large protein is limited: the N-terminal region interacts with partner and localizer of BRCA2 (PALB2) [24] [25] [26] [27] , a central domain interacts with the meiotic recombinase DMC1 (ref. 28 ) and the C-terminal region contains an α-helical domain followed by three oligonucleotideoligosaccharide-binding (OB) folds (residues 2480-3190) that bind ssDNA 29 .
Owing to the large size of BRCA2, which hinders structural studies, BRCA2's precise functions in promoting RAD51-mediated HR remain poorly defined. Here, we set out to use biochemical and structural approaches to provide mechanistic insights into how full-length BRCA2 interacts with RAD51 and ssDNA to promote formation of RAD51 nucleoprotein filaments. Our results show that BRCA2 stimulates the nucleation of RAD51 filaments and facilitates unidirectional 3′-5′ filament growth, two processes essential for successful DSB repair and/or replication-fork restart.
RESULTS

Structural organization of the BRCA2 dimer
To provide mechanistic insights into the role of BRCA2 in recombinational repair, we set out to provide a structural characterization of full-length BRCA2 and the BRCA2-RAD51 complex. To do this, we visualized purified BRCA2 (ref. 20) (Supplementary Fig. 1a ) by EM. Negatively stained EM images of BRCA2 showed a range of particle sizes with relatively low abundance ( Supplementary Fig. 2) , thus precluding them from high-resolution cryo-EM three-dimensional (3D) reconstructions. However, we selected a total of 8,873 negatively stained particles and subjected them to multivariate statistical analysis and classification. We used selected class averages to generate a 3D reconstruction with angular-reconstitution methodologies 30 and iteratively refined the 3D structure in IMAGIC 31 . The initial eigenimages and 3D reconstructions showed a two-fold symmetry suggestive of a dimer (Supplementary Fig. 3 ). After several cycles of refinement without imposed symmetry, we carried out subsequent refinement with two-fold symmetry imposed. The reprojections from the 3D model were in excellent agreement with the corresponding class averages ( Supplementary Fig. 3c ), and the final 3D reconstruction incorporated the vast majority of the data set at a resolution of 18.5 Å by 0.5 Fourier shell correlation (FSC) criterion ( Supplementary  Fig. 4 ). We validated the 3D reconstruction by using tilt-pair and tilt-series analyses 32, 33 (Supplementary Fig. 4) .
The 3D reconstruction of BRCA2 revealed a slightly curved, elongated molecule of ~250 Å × 135 Å × 120 Å ( Fig. 1a) . As viewed from the concave face (top view), the elliptic density contains two halves that enclose a central channel, with the main density forming a smooth arc at the far end and with the two halves being connected by elongated density at the outer rim of the channel. From the side view, the molecule displays a kidney-bean shape with a groove in the middle and a relatively flat base at the bottom. When viewed from the bottom, the central channel is enclosed by distinct regions of density arranged in a rectangular shape.
Owing to BRCA2's large size, and the difficulty in obtaining sufficient amounts of protein, we were unable to use internal labeling and nanogold particles to identify functional domains within the reconstruction. We therefore used antibodies (which have a distinct Y shape in negative-stain EM) against BRCA2's C-terminal Flag tag to visualize this region of the protein. We then assigned Euler angles to the BRCA2 particles with antibodies attached to them ( Fig. 1b) , by using the BRCA2 3D reconstruction. From the Euler-angle assignments of individual particles and the locations of the antibody, we obtained the 3D position of the antibody through triangulation (Supplementary Fig. 3d ) and found that the C terminus was located at the top and near the far end of the BRCA2 dimer ( Fig. 1b-d ; Fig. 1h ,i, blue surface). Similarly, we identified the location of the BRC repeats by using an antibody against a region between BRC5 and BRC6 ( Fig. 1e-g ) and found that it was located at the outer rim and toward the top of the 3D structure ( Fig. 1h,i , purple surface).
Structure of the BRCA2-RAD51 complex
Previously, it was shown that BRC repeats 1-4 exhibit a higher affinity for RAD51 than do BRC repeats 6-8 (refs. 16,17,34) . Accordingly, four to six RAD51 molecules are bound by the BRCA2 monomer 21 .
To investigate the spatial arrangement of RAD51 within the context of BRCA2, we mixed an excess of purified RAD51 with BRCA2 and affinity-purified the BRCA2-RAD51 complex ( Supplementary  Fig. 1a ). We then visualized the complex by EM and determined the 3D structure. We obtained images of 6,877 particles and performed independent image processing without using the BRCA2 3D reconstruction as references for alignment or angular assignment, in order to avoid any potential model bias. Interestingly, the particle sizes were again consistent with BRCA2 existing as dimers, thus indicating that RAD51 binding does not dissociate the dimer. Initial eigenimages and class averages revealed two-fold symmetry and elongated particles, except that the particles appeared wider than the BRCA2 particles ( Supplementary Figs. 3 and 5) .
The final 3D reconstruction by angular reconstitution followed by iterative cycles of refinement was at 19.5-Å resolution, and it incorporated the vast majority of the data set ( Fig. 2) . We validated the structure by using similar approaches to those used for the BRCA2 reconstruction and again found two halves connected by an elongated density along the outer rim of a central cage ( Fig. 2a,b) . The structure is longer (265 Å versus 250 Å), wider (165 Å versus 135 Å) and taller (165 Å versus 120 Å) than BRCA2 alone. In addition, in the BRCA2-RAD51 complex, we did not find a cavity at the bottom of the BRCA2 dimer, and the reconstruction, when viewed from the a r t i c l e s npg a r t i c l e s side, displayed a more triangular shape ( Fig. 2b) that contrasted with the BRCA2 reconstruction, which had a clear groove at the top and a relatively flat base at the bottom (Fig. 1a) . Another notable feature was the extra density along the sides of the central cavity region toward the top of the BRCA2-RAD51 complex; this contributed to the increased width and the loss of the clear groove (comparison of Figs. 1 and 2) .
Owing to the observed changes in the overall shape between the BRCA2 and BRCA2-RAD51 reconstructions, it was not immediately obvious which density region contained RAD51. However, the location of the BRC repeats ( Fig. 1) suggested that RAD51 binds to the sides and between the two halves of the arc-like globular density. To determine whether this was the case, we probed the complex with an antibody against RAD51 and found that it bound to a region consistent with the location of the BRC repeats ( Fig. 2c; Fig. 2d , orange surface). These results support the view that RAD51 is located at the outer rim of the central cage region between the two arc-shaped halves of the reconstruction toward the top of the molecule (viewed from the side).
Conformational changes of BRCA2 upon RAD51 binding
Because RAD51 binds toward the top of the BRCA2 dimer, the altered shape observed at the bottom of the BRCA2-RAD51 reconstruction, compared with that of BRCA2 alone, indicated that RAD51 binding induced structural rearrangements ( Fig. 3a) . Clear differences were apparent in the steep slope, visible in the side view, a pointed tip at the base of the reconstruction and the disappearance of the channel at the bottom ( Figs. 2a and 3a) . The slope indicated a tilt of each monomer toward the vertical axis relative to the dimer plane. In BRCA2, the channel at the bottom is formed by two L-shaped densities, and we propose that each L shape is contributed by a BRCA2 monomer (Fig. 1a, bottom view) . The closure of the channel in the BRCA2-RAD51 complex indicated that the L-shaped density was reorganized and became more closely associated in an intercalated arrangement. Using the segmentation command implemented in Chimera 35 , we separated the BRCA2 density into two halves ( Fig. 1a  and Fig. 3 , yellow and cyan density regions) and fitted the two halves independently into the BRCA2-RAD51 density (Fig. 3b) . This resulted in an increase in the correlation coefficient between BRCA2 and BRCA2-RAD51 reconstructions from 0.64 to 0.78. Although there are some uncertainties in the exact boundary of the BRCA2 monomers, the rearrangement mainly involved a rotation and tilt of the two monomers ( Fig. 3b) to accommodate the steep slope on the side of the molecule. This rearrangement resulted in extra density at the top that connects the two halves of the dimer (Fig. 3b) , results consistent with the RAD51 antibody-labeling data (Fig. 2d) . This extra density region could accommodate approximately four RAD51 monomers, arranged in a filament-like fashion, on each side ( Fig. 3c,d) .
To confirm that BRCA2 remained as a dimer upon binding to RAD51, we carried out mass measurements of the BRCA2-RAD51 complex by using scanning transmission electron microscopy (STEM). The histogram showed two major populations at ~800 kDa and ~1,200 kDa respectively, in agreement with the presence of BRCA2 dimers and their complex with 8-10 RAD51 molecules ( Fig. 3e) . Our data therefore indicate that the BRCA2 dimer binds to two sets of RAD51 molecules and that each set can accommodate approximately four or five RAD51 monomers that bind in between the two BRCA2 monomers toward the top of the molecule (Fig. 3c) .
DNA binding of BRCA2 and the BRCA2-RAD51 complex
An important property of BRCA2 is its preference for binding to ssDNA rather than double-stranded DNA (dsDNA) 20 npg a r t i c l e s binding specificity of BRCA2 is critical for the association of RAD51 with ssDNA because RAD51 alone binds to both ssDNA and dsDNA with similar affinities 20, [36] [37] [38] . To understand how BRCA2 binds ssDNA and recruits RAD51, we determined the minimum length of ssDNA required for BRCA2 binding. With 32 P-labeled oligonucleotides of defined length (20-100 nucleotides (nt)), electromobility shift assays (EMSAs) revealed that the minimum binding size for the formation of a stable BRCA2-ssDNA complex was approximately 50 nt, although longer oligonucleotides (>66 nt) were required for maximal binding ( Fig. 4a) . We observed little or no binding with ssDNAs shorter than 40 nt. In contrast, previous studies using only the DNA-binding domain of BRCA2 showed that it exhibits weak binding to 12-20 nt, whereas stronger binding occurred with oligonucleotides that were 36 nt in length 39 . Our results are therefore consistent with the notion that the stable association of BRCA2 with ssDNA may require simultaneous binding to both subunits of the dimer. We next visualized the BRCA2-ssDNA complex in order to determine the path of the DNA across BRCA2. Because ssDNA is difficult to see by negative staining, whereas dsDNA can be observed, we used gapped duplex DNA in which ssDNA regions (70 or 100 nt in length) were flanked by duplex arms of 65 or 50 base pairs. The gaps were large enough to accommodate a BRCA2 dimer for maximal DNA binding, and the duplex arms allowed us to define the path of the DNA (Fig. 4b) . We confirmed binding to the gapped duplex DNA by EMSA (Supplementary Fig. 1c ). We analyzed particles in which we could see DNA bound to BRCA2 by projection-matching, using the BRCA2 3D reconstruction. The observed relative positions of the dsDNA arms were consistent with a model in which ssDNA binds along the long axis of the BRCA2 dimer (Fig. 4b) . These results are in agreement with the location of the C terminus of BRCA2, as determined by antibody labeling, because the C terminus is close to the DNA-binding domain (Fig. 1h,i) .
To address how BRCA2 recruits RAD51 to ssDNA, we visualized the assembly of BRCA2-RAD51-ssDNA on linear ϕX174 ssDNA. We adsorbed RAD51-ssDNA, BRCA2-ssDNA and BRCA2-RAD51-ssDNA complexes, formed at short incubation times, onto carbon grids, negatively stained with uranyl acetate and acquired images for analysis ( Fig. 4c-e ). As expected, BRCA2 formed discrete particles that could be visualized quite easily, owing to their large size npg a r t i c l e s ( Fig. 4d) . However, we obtained striking results when we viewed the BRCA2-RAD51-ssDNA samples: we observed many examples in which BRCA2 particles were positioned at only one end of the RAD51-ssDNA filaments (Fig. 4e) . Because BRCA2 carried a C-terminal Flag tag, we confirmed that these terminal particles were indeed BRCA2 by using a monoclonal anti-Flag antibody coupled to 20-nm gold particles (Fig. 4f) . At longer reaction time points, we observed BRCA2 only infrequently, thus indicating that it may dissociate once nucleoprotein filament formation has been initiated. The visualization of BRCA2-RAD51-ssDNA filaments indicated unidirectional growth of the RAD51 filament from BRCA2. To determine the polarity of filament growth, we generated linear ssDNA molecules that were gold-labeled at either their 5′ or their 3′ termini. EM analysis revealed that RAD51 filaments extended from BRCA2 to the 5′-gold label (Fig. 4g) . In contrast, we failed to detect similar complexes oriented in the opposite direction (5′-3′) when using 3′-gold-labeled ssDNAs (data not shown). Our interpretation of these results is that RAD51 filaments grow from BRCA2 in the 3′-5′ direction, consistently with the 3′-5′ polarity of strand transfer relative to bound ssDNA 40, 41 .
BRCA2 promotes increased nucleation of RAD51-ssDNA filaments
We next determined whether BRCA2 influences the nature of the filaments formed. We observed only short filaments (40-100 nm) in the presence or absence of BRCA2 (Fig. 5a,b) . Quantification of the average filament length revealed little or no change in length as a consequence of BRCA2 inclusion (Fig. 5c) . The presence of BRCA2, however, led to a substantial increase in the number of RAD51 filaments. To confirm this, we investigated the initial nucleation events and found that approximately four times more RAD51-ssDNA nucleation events occurred in the presence of BRCA2 than in its absence (Fig. 5a,b; quantified in Fig. 5d and Supplementary  Fig. 1b) . Interestingly, we also observed multiple BRCA2 particles and short RAD51 filaments aligned in a linear fashion (Fig. 5e) , presumably along a single ssDNA molecule, thus suggesting that BRCA2 (and therefore BRCA2-RAD51) can bind to multiple sites along the ssDNA and initiate multiple nucleation events.
When taken together, our data show that BRCA2 facilitates the interaction of RAD51 with ssDNA by creating nucleation sites from which RAD51 self-polymerizes with a 3′-5′ directionality. In agreement with previous data 42 , filament assembly involves the formation of multiple nucleation clusters and subsequent gap filling rather than the progressive elongation of RAD51 filaments from just a small number of nucleation sites. The extension of these short nascent filaments into a single extended filament capable of efficient homologous pairing and strand exchange may require the actions of other RAD51-mediator proteins including PALB2, RAD52, RAD54 and/or the RAD51 paralogs.
DISCUSSION
Our results reveal new insights into the role of BRCA2 in driving RAD51 filament formation. Specifically, we report the first detailed view, to our knowledge, of the structure of full-length BRCA2, showing that (i) a BRCA2 dimer recruits two sets of RAD51 molecules arranged in opposing orientations, (ii) ssDNA binds across one surface of the BRCA2 dimer, (iii) BRCA2 increases the frequency, but not the length, of nascent RAD51 filament nucleation events and (iv) BRCA2 facilitates unidirectional 3′-5′ filament growth from each nucleation site.
Our data show that purified BRCA2 exists predominately in dimeric form and that dimers bind RAD51 and ssDNA without dissociation. Approximately four or five RAD51 monomers bind into each BRCA2 subunit. Consistently with this, four or five RAD51 monomers represent the minimal nucleation length that enables filament growth 43 . Each BRC repeat can mimic the RAD51 intersubunit elements required for filament and ring contacts; this supports the concept that the RAD51 monomers are aligned by BRC binding in preparation for nucleation on ssDNA. Owing to the intrinsic symmetry imposed by the BRCA2 dimer, the two sets of RAD51 molecules bound to the dimer are oriented in opposing directions (Fig. 6) . Upon ssDNA binding, which imposes polarity, only one set of RAD51 molecules will be in the correct polarity for interaction with ssDNA ( Fig. 6) . Dimers therefore offer certain mechanistic advantages because they allow BRCA2 to bind ssDNA in either orientation and still present one set of RAD51 molecules in the correct orientation for productive filament formation. However, we cannot exclude the possibility that upon interaction with other partners, such as PALB2 or BRCA1, or upon the introduction of DNA damage or cell cycle-mediated post-translational modifications, a dimer-tomonomer transition occurs. Such a mechanism has been proposed for Ustilago maydis Brh2, in which a dimer-to-monomer transition occurs upon DSS1 binding 44 . In avian DT40 cells, a transition from slower-diffusion species of BRCA2 (i.e., larger macromolecular assemblies) to species capable of faster diffusion (i.e., smaller assemblies) has been observed upon DNA damage 45 . Dimer-to-monomer transitions have previously been proposed as key regulatory mechanisms for a number of DNA-damage signaling and repair proteins, such as ATM or ATR 46 . However, in contrast to ATM or ATR, BRCA2 dimers are active in terms of ssDNA binding and RAD51 filament a r t i c l e s formation. Whether or not BRCA2 monomers can promote filament formation remains to be determined.
How might ssDNA, which has a defined polarity, bind across BRCA2? The BRCA2 DNA-binding region consists of four domains including an α-helical domain and three OB folds (Fig. 6) , with OB2 and OB3 having a higher affinity than α-helical-OB1 for ssDNA (ref. 29) . This region binds ssDNA of 12-20 nt weakly and ssDNA of 36 nt tightly, thus suggesting that it resembles the ssDNA-binding protein RPA. In support of the analogy between the BRCA2 and RPA DNA-binding domains, a heterologous fusion protein containing BRC repeats fused to the large subunit of RPA can at least partially complement BRCA2-mutant cells 47 . RPA uses two of its five OB folds for the weak 8-nt binding mode and four OB folds for tight 30-nt binding 29, 48 . Crystallographic analysis of RPA in complex with a 30-mer revealed that the four ssDNA-binding OB folds, which are arranged in a compact quaternary structure, cause the ssDNA to take a U turn 49 (Fig. 6a) . The four DNA-binding domains of BRCA2 may be arranged in a similar compact fashion to those in RPA, and only two out of the four domains could be used for ssDNA binding (Fig. 6a) . Thus, irrespective of its relative polarity, ssDNA could bind to two of the four DNA-binding domains in one BRCA2 monomer (for example, Fig. 6a,b , left monomer, domains 3 and 4 (OB2 and OB3)). Owing to the symmetry imposed by the dimer, two different domains (domains 1 and 2 (helical domain and OB1)) in the other BRCA2 monomer would bind to ssDNA with the same polarity ( Fig. 6a,b , right monomer), thus allowing the correct polarity for ssDNA binding in both monomers. Our observation that BRCA2 requires 40 nt of ssDNA for weak binding and >70 nt for maximal binding supports the notion that the two DNA-binding domains in each monomer act in concert.
Recombination is initiated at long 3′-ssDNA tails that form by DSB resection. These tails serve as targets for multiple BRCA2-mediated nucleation events merging to form a single RAD51-ssDNA filament that will initiate homologous pairing. Our analysis of the BRCA2-RAD51-ssDNA complex indicates that BRCA2 is located at the 3′ end of each nucleating RAD51 filament, thus supporting a model in which RAD51 filaments grow in the 3′-5′ direction, consistent with the polarity of RAD51-mediated strand exchange 40, 41 . One possibility is that BRCA2 'caps' one end of the filament (the 3′ end) and blocks dissociation while allowing RAD51 to self-polymerize and grow at the other end. RAD51 polymerization in the 3′-5′ direction may lead to a situation in which several nucleotides at the 3′ terminus itself will not be bound by RAD51. This is unlikely to be a problem, however, because a free end is not required for pairing 50, 51 , and it has been shown that RAD51 can promote the initial ssDNA-dsDNA pairing interactions at both 3′-and 5′-extended ssDNA tails 52, 53 . Once pairing is initiated, however, only an invading 3′ terminus can act as a primer for DNA-repair synthesis.
Interestingly, the Brh2 protein preferentially binds at single-and double-stranded junctions in DNA and stimulates RAD51 filament formation at a 3′ ssDNA overhang 54 . However, BRCA2 fails to exhibit a preference for binding junctions over ssDNA 20, 21 . Given that BRCA2 caps the 3′ end of the RAD51 filament, which grows 3′-5′, these observations suggest that some differences exist between BRCA2 and Brh2, but whether these differences reflect mechanistic diversity between the two proteins or are due to different experimental conditions is presently unclear.
In contrast to RAD51, Escherichia coli RecA binds ssDNA and promotes strand exchange with a 5′-3′ polarity [55] [56] [57] . This difference might be due to the presence of an additional N-terminal domain in RAD51, whereas RecA has a C-terminal addition, because these domains are positioned on opposing sides of the ATPase core relative to ssDNA (Supplementary Fig. 6a ). In RAD51, filament formation involves a β-strand connecting the N-terminal domain with the ATPase domain, and this is stabilized and ordered upon binding to the ATPase domain of the adjacent monomer. This interaction surface is therefore enhanced and stabilized at the growing end of the filament toward the N-terminal, or 5′, direction (Supplementary Fig. 6b ). In RecA, however, there is a loop involved in subunit interactions that is ordered only in the filament. This loop is located toward the 3′ direction, such that subunit addition in this direction would stabilize the loop and subsequent interactions (Supplementary Fig. 6b) . Owing to the distinct domain configurations and the locations of the loop regions, RAD51 and RecA filaments thus grow in opposite directions (Supplementary Fig. 6b,c) .
In summary, the results presented here indicate a model in which a BRCA2 dimer binds to two sets of RAD51 molecules. Upon ssDNA binding, only one set of RAD51 molecules can bind ssDNA, owing to the inherent polarity of the bound ssDNA. The RAD51 filament then grows in the 3′-5′ direction, governed by its molecular architecture, leaving BRCA2 to cap the 3′ end of the filament (Fig. 6c) . Given that only very small amounts of BRCA2 are required for RAD51 filament nucleation, we suggest that BRCA2 dissociates once the nascent filament undergoes extension and can subsequently be used once more to initiate the formation of another filament. In so doing, BRCA2 acts as a molecular chaperone for filament assembly.
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